Clinical Trial Update: Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and immunogenicity of a Sabin Inactivated Poliovirus Vaccine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis
• Post-polio Syndrome

Drugs mentioned

• Sabin Inactivated Poliovirus Vaccine (inactivated poliovirus vaccine (Sabin strain))

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Polio and Post-Polio Syndrome | Phase 2 | Status: COMPLETED